AK
Anil Kumar Chopra
About Anil Kumar Chopra
Data last updated:
Anil Kumar Chopra is a Director at Ojal Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Ojal Pharmaceuticals Private Limited reported revenue of ₹26.1 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ojal Pharmaceuticals Private Limited U24290MP2019PTC047557 | Director | 27 Dec 2019 | 2019 | ₹26.1 Lakh (FY 2024) | Active |
Board colleagues of Anil Kumar Chopra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Giriraj Gupta | 08318110 | Ojal Pharmaceuticals Private Limited | Director |
| Kirti Shah | 10465941 | Ojal Pharmaceuticals Private Limited | Additional Director |
| Surbhi Gupta | 10465943 | Ojal Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Kumar Chopra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Kumar Chopra
Anil Kumar Chopra currently holds 1 directorship: Ojal Pharmaceuticals Private Limited (Director, since 27 Dec 2019, revenue ₹26.1 Lakh (FY 2024)).
Anil Kumar Chopra was first appointed on 27 Dec 2019 as Director at Ojal Pharmaceuticals Private Limited.
The current boards of Anil Kumar Chopra's companies include Giriraj Gupta (Ojal Pharmaceuticals Private Limited), Kirti Shah (Ojal Pharmaceuticals Private Limited), Surbhi Gupta (Ojal Pharmaceuticals Private Limited).